Molecular Mechanisms of Right Ventricular Failure
- PMID: 26527692
- PMCID: PMC4635965
- DOI: 10.1161/CIRCULATIONAHA.114.012975
Molecular Mechanisms of Right Ventricular Failure
Abstract
An abundance of data has provided insight into the mechanisms underlying the development of left ventricular (LV) hypertrophy and its progression to LV failure. In contrast, there is minimal data on the adaptation of the right ventricle (RV) to pressure and volume overload and the transition to RV failure. This is a critical clinical question, because the RV is uniquely at risk in many patients with repaired or palliated congenital heart disease and in those with pulmonary hypertension. Standard heart failure therapies have failed to improve function or survival in these patients, suggesting a divergence in the molecular mechanisms of RV versus LV failure. Although, on the cellular level, the remodeling responses of the RV and LV to pressure overload are largely similar, there are several key differences: the stressed RV is more susceptible to oxidative stress, has a reduced angiogenic response, and is more likely to activate cell death pathways than the stressed LV. Together, these differences could explain the more rapid progression of the RV to failure versus the LV. This review will highlight known molecular differences between the RV and LV responses to hemodynamic stress, the unique stressors on the RV associated with congenital heart disease, and the need to better understand these molecular mechanisms if we are to develop RV-specific heart failure therapeutics.
Keywords: angiogenesis; heart defects, congenital; heart failure; hypertrophy; oxidative stress.
© 2015 American Heart Association, Inc.
Conflict of interest statement
Figures
References
-
- Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900. - PubMed
-
- Belmont JW. Recent progress in the molecular genetics of congenital heart defects. Clin Genet. 1998;54:11–19. - PubMed
-
- Lund O, Kristensen LH, Baandrup U, Hansen OK, Nielsen TT, Emmertsen K, Jensen FT, Flo C, Rasmussen BS, Pilegaard HK. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J. 1998;19:1099–1108. - PubMed
-
- Douglas PS, Reichek N, Hackney K, Ioli A, Sutton MG. Contribution of afterload, hypertrophy and geometry to left ventricular ejection fraction in aortic valve stenosis, pure aortic regurgitation and idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;59:1398–1404. - PubMed
-
- Kaufman BD, Desai M, Reddy S, Osorio JC, Chen JM, Mosca RS, Ferrante AW, Mital S. Genomic profiling of left and right ventricular hypertrophy in congenital heart disease. J Card Fail. 2008;14:760–767. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
